Technical Analysis for IPHA - Innate Pharma S.A.

Grade Last Price % Change Price Change
F 4.22 -4.09% -0.18
IPHA closed down 4.09 percent on Monday, April 19, 2021, on 30 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical IPHA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.09%
20 DMA Support Bullish -4.09%
Bollinger Band Squeeze Range Contraction -4.09%
Narrow Range Bar Range Contraction -4.09%
NR7 Range Contraction -4.09%
Inside Day Range Contraction -4.09%
Older End-of-Day Signals for IPHA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Resistance about 13 hours ago
Down 2 % about 14 hours ago
Down 1% about 14 hours ago
Fell Below 20 DMA about 14 hours ago
Fell Below 10 DMA about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Innate Pharma SA is a biopharmaceutical company, which focuses on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. Its products include immunotherapy drugs and monoclonal antibodies. The Immunotherapy drugs are designated for cancer and inflammatory diseases. The Monoclonal antibodies targets receptors and pathways controlling the activation of innate immunity cells. The company was founded by Hervé Brailly, Eric Vivier, Marc Bonneville, Alessandro Moretta, Jean-Jacques Fournié and François Romagné on September 15, 1999 and is headquartered in Marseille, France.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Immunology Immune System Immunotherapy Antibodies Monoclonal Antibody Monoclonal Antibodies Antibody Inflammatory Disease Inflammatory Diseases Cancer Treatment Immunity

Is IPHA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.23
52 Week Low 3.55
Average Volume 30,532
200-Day Moving Average 4.84
50-Day Moving Average 4.44
20-Day Moving Average 4.35
10-Day Moving Average 4.32
Average True Range 0.17
ADX 19.21
+DI 16.51
-DI 34.42
Chandelier Exit (Long, 3 ATRs ) 4.13
Chandelier Exit (Short, 3 ATRs ) 4.49
Upper Bollinger Band 4.55
Lower Bollinger Band 4.15
Percent B (%b) 0.17
BandWidth 9.13
MACD Line -0.04
MACD Signal Line -0.04
MACD Histogram -0.0004
Fundamentals Value
Market Cap 333.22 Million
Num Shares 79 Million
EPS
Price-to-Sales 6.51
Price-to-Book 1.57
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.52
Resistance 3 (R3) 4.54 4.46 4.47
Resistance 2 (R2) 4.46 4.38 4.45 4.45
Resistance 1 (R1) 4.34 4.34 4.30 4.32 4.44
Pivot Point 4.26 4.26 4.24 4.25 4.26
Support 1 (S1) 4.14 4.18 4.10 4.12 4.00
Support 2 (S2) 4.06 4.14 4.05 3.99
Support 3 (S3) 3.94 4.06 3.97
Support 4 (S4) 3.92